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Abstract. A new one pot reaction of substituted thiosemicarbazides with 2-bromoacetophenone and 
carbonyl compounds gave 2-hydrazonothiazoles in good yields. The structures of the isolated compounds 
were corroborated by NMR, IR, mass spectra and elemental analyses in addition to X-ray structure 
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1. Introduction 
1,3-thiazole moiety is one of the most important scaffolds in heterocyclic chemistry and drug design and 
discovery [1]. It is widely found in diverse pharmacologically active substances and in some naturally-
occurring compounds [1]. It was reported that substituted 2-hydrazino-1,3-thiazoles show an inhibitory 
activity (MIC of 16l µg/mL) against a resistant strain of Candida krusei [2].  Few other 2-hydrazino-1,3-
thiazole analogues that exhibit significant antimicrobial activity have been recently reported in the literature 
[3]. Thiazoles bearing a bicyclic or heterocyclic ring on the hydrazone function and a phenyl at C-4 position 
of the thiazole nucleus are particularly active and present micromolar or submicromolar MIC against several 
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Candida spp. Strains (repeated) [1]. Thus, such scaffolds could be seen as a starting point for further 
optimization of novel antifungal agents.  
Thiazoles and their analogues serve also as precursors for the synthesis of biologically active compounds 
[4]. They were reported to possess antimicrobial [5-8], analgesic [9], anti-inflammatory [10], anticonvulsant 
[11], cardiotonic [12], anticancer [13-15], antitubercular [16] and anthelmintic [17] effects. (it is better to 
start with this paragraph) Several methods for the synthesis of thiazole derivatives have been developed [18-
20], the most widely used is being the Hantzsch synthesis, which uses thioamides and α‐halocarbonyl (or α‐
halo ester) compounds as starting materials [21].  
It was previously shown that ylidenes of hydrazinothiazoles could be synthesized by two different methods: 
a) reaction of hydrazinothiazoles with the appropriate ketones or aldehydes or b) reaction between 
thiosemicarbazides and 2-bromoacetophenones. The yields of the methods described have been suffered 
from long time of reaction. Our recent publication includes the synthesis of versatile, hitherto thiazole 
derivatives resembling LY293111 [22]. Besides that, we reported on thiazole synthesis via donor-acceptor 
reactions [23-25]. To address these interesting biological and pharmaceutical properties and their synthetic 
utility, we aim to design a new facile method in order to prepare ylidenes of hydrazonothiazoles in a one pot 
reaction starting from substituted thiosemicarbazides, 2-bromoacetophenones and ketones. 
2. Results and Discussion 
 
Scheme 1. Synthesis of 2-ylidenes of hydrazonothiazoles 6a-e 
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The compounds 3a-c [26] were previously prepared on one hand by reaction of substituted 
thiosemicarbazides 1a-c with 2-bromo-acetophenone (2) (Scheme 1, method A). On the other hand, reaction 
of 1a-c with appropriate ketones 4a,b, gave the corresponding thiosemihydrazones 5a-e [27] and upon 
subjecting compounds 5a-e with bromide 2, the corresponding 2-ylidenes of hydrazinothiazoles 6a-e were 
obtained in moderate yields (Scheme 1, method B). The yields of the products 6a-e (i.e. preparation of 
compounds 6a-d according to lit [28]) using the two aforesaid procedures were not optimal (Scheme 1).  
We herein reported on one-pot method using a mixture of 1a-c, 2 and 4a,b (Scheme 1, method C). The 
yields of compounds 6a-e using the method C are shown in Table 1. The distinctive carbons of the aforesaid 
compounds are shown in Figure 1. The structures of the isolated products were confirmed by mass, NMR, 
IR spectra in addition to elemental analyses. For example, the NMR spectroscopic data of compounds 6a 
and 6b are shown in Tables 2 and 3.  
Table 1. Yields of compounds 6a-e using method C 
Compound Yield (%) 
6a 92 
6b 95 
6c 93 
6d 78 
6e 94 
 
Figure 1. Distinctive carbons of compounds 6a and 6b 
 
Table 2. NMR spectroscopy of 6a 
1H NMR:   COSY:                        Assignment 
7.33 (“t”, J = 7.5; 2H) 7.22, 7.15                                H-m 
7.22 (m; 6H)   7.33, 7.15              H-o, m’, p, p’ 
7.15 (m; 2H)   7.33, 7.22              H-o’ 
6.51 (s; 1H)                  H-5 
1.91 (s; 3H)                  H-2d/2d’ 
1.79 (s; 3H)                  H-2d’/2d 
13C NMR:  HSQC:                  HMBC:            Assignment: 
165.94    6.51, 1.91, 1.79      C-2 
158.86    1.91, 1.79                             C-2c 
139.08, 138.06   7.33, 7.22, 7.15, 6.51                  C-i, 4 
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131.05    7.22, 7.15, 6.51      C-i’ 
128.52   7.33  7.33, 7.22, 7.15, 6.51                 C-m 
128.32, 128.19 7.22  7.33, 7.22, 7.15, 6.51                 C-o, m’ 
128.14   7.22  7.33, 7.22, 7.15, 6.51                 C-p/p’ 
127.89   7.15  7.33, 7.22, 7.15, 6.51                 C-o’ 
127.23   7.22  7.33, 7.22, 7.15, 6.51                 C-p’/p 
100.95   6.51                     C-5 
24.30   1.91  1.79                   C-2d/2d’ 
18.17   1.79  1.91                   C-2d’/2d 
15N NMR:            HSQC:                  HMBC:      Assignment: 
344.5                           1.91, 1.79        N-2b 
138.5                           7.22, 6.51        N-3 
 
Table 3. NMR spectroscopy of compound 6b 
1H NMR:                   COSY:           Assignment: 
7.81 (dd, J = 8.0, 1.5; 2H)                  7.37    H-o” 
7.37 (m; 5H)        7.81, 7.30, 7.26             H-m, m”, p” 
7.30 (m; 3H)        7.37, 7.26, 7.19             H-o, p/p’ 
7.26 (m; 3H)        7.37, 7.30, 7.19             H-m’, p’/p 
7.19 (m; 2H)        7.30, 7.26              H-o’ 
6.66 (s; 1H)                              H-5 
2.20 (s; 3H)                              H-2d 
15N NMR:             HSQC:  HMBC:  Assignment:  
354.1  2.20                                                N-2b 
142.6  6.66                                                      N-3 
13C NMR:  HSQC:  HMBC:      Assignment: 
168.90     6.66, 2.20               C-2 
155.80     7.81, 2.20               C-2c                                   
139.57     7.26, 7.19, 6.66              C-4 
    138.25, 137.71               7.37, 7.30, 2.20              C-i, i” 
    130.77     7.26, 6.66    C-i’ 
     128.88   7.37  7.81, 7.37, 7.30, 7.26, 7.19, 6.66 C-p” 
     128.69   7.37       C-m 
     128.40   7.30       C-o’ 
     128.33   7.26       C-p/p’ 
     128.25   7.37       C-m’ 
     128.22   7.37       C-m” 
     128.09   7.19       C-o’ 
     127.64   7.30       C-p’/p 
     125.90   7.81  7.81, 7.37    C-o” 
     102.02   6.66       C-5 
     14.40   2.20       C-2d 
 
The X-ray structure analysis confirmed the structure of 6a as shown in Figure 2. The stereochemistry of 
compound 6a was determined with a Z, s-trans (transoid) configuration for the CNN moiety and the 
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compound was identified finally as (Z,s-trans)-3,4-diphenyl-propan-2-ylidenehydrazono-2,3-dihydro-
thiazole.  
 
 
Figure 1. Molecular structure of 6a (displacement parameters are drawn at 50% probability level) 
3. Experimental Part 
3.1. General 
Melting points were determined using an APP Digital ST 15 melting point apparatus and uncorrected. TLC 
analyses were performed using analytical Merck 9385 silica aluminum sheets (Kieselgel 60) with PF254 
indicator. The IR spectra were recorded as KBr disks on Shimadzu-408 infrared spectrophotometer, Faculty 
of Science, Minia University. The NMR spectra were measured using a Bruker AV-400 spectrometer at the 
Karlsruher Institut für Technologie (KIT), Institute of Organic Chemistry, Karlsruhe, Germany. Chemical 
shifts were expressed as δ (ppm) with tetramethylsilane as internal reference. The samples were dissolved in 
DMSO-d6, s = singlet, d = doublet, dd = doublet of doublet and t = triplet. Mass spectrometry were recorded 
on a Varian MAT 312 instrument in EI mode (70 eV), at the Karlsruhe Institut für Technologie (KIT), 
Institute of Organic Chemistry, Karlsruhe, Germany. Elemental analyses were carried out using Varian 
Elementary device in National Research Center, Giza, Egypt. 
3.2. Crystal Structure Determination of 6a 
The single-crystal X-ray diffraction study was carried out on a Bruker D8 Venture diffractometer with 
Photon100 detector at 123(2) K using Cu-K radiation ( = 1.54178 Å). Dual space methods (SHELXT) 
[29] were used for structure solution and refinement was carried out using SHELXL-2014 (full-matrix least-
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squares on F2) [29]. Hydrogen atoms were refined using a riding model. A semi-empirical absorption 
correction and an extinction correction were applied. 
6a: Yellow crystals, C18H17N3S, Mr = 307.40, crystal size 0.20 × 0.08 × 0.04 mm, monoclinic, space group 
P21/c (No. 14), a = 5.8645(2) Å, b = 14.0488(5) Å, c = 18.7533(7) Å, β = 97.003(2)°, V = 1533.11(10) Å3, Z 
= 4, ρ = 1.332 Mg/m-3, µ(Cu-Kα) = 1.857 mm-1, F(000) = 648, 2max = 144.4°, 16566 reflections, of which 
3015 were independent (Rint = 0.025), 202 parameters, R1 = 0.029 (for 2856 I > 2σ(I)), wR2 = 0.072 (all 
data), S = 1.04, largest diff. peak / hole = 0.255 / -0.240 e Å-3. 
CCDC 1896104 (6a) contains the supplementary crystallographic data for this paper. These data can be 
obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif.  
3.3. Starting materials 
Compounds 3a-c and 5a-e were prepared according to literature [26] and [27], respectively (see their 
corresponding references). Compounds 6a-d were prepared for comparison according to literature [28]. 
3.4. General procedure describes preparation of compounds 6a-e 
A mixture of 1a-c, 2 and 4a,b (1 mmol) in absolute ethanol (EtOH, 150 mL), was stirred at room 
temperature for 6-10 h (the reaction was monitored by TLC). The reaction mixture was allowed to stand 
overnight. The formed products were recrystallized from the stated solvents. 
(Z)-3,4-Diphenyl-2-(propan-2-ylidenehydrazono)-2,3-dihydrothiazole (6a). Pale yellow crystals (EtOH), 
Rf = 0.5 (Toluene: Ethyl acetate: 10:1), yield 0.283 g (92%), m.p. 165-167 
oC (m.p. [28a] 165 °C). NMR 
(CDCl3): see Table 2. Anal. Calcd. For C18H17N3S (307.42): C, 70.33; H, 5.57; N, 13.67. Found: C, 70.22; 
H, 5.45; N, 13.55. 
(Z)-3,4-Diphenyl-2-((E)-1-phenylethylidene)hydrazono)-2,3-dihydrothiazole (6b). Pale yellow crystals 
(EtOH), Rf = 0.4 (Toluene: Ethyl acetate: 10:1), yield 0.350 g (95%), m.p. 310-312 
oC (m.p. [28b] 310-312 
°C). NMR (CDCl3): see Table 3. Anal. calcd. for C23H19N3S (369.49): C, 74.77; H, 5.18; N, 11.37. Found: 
C, 74.62; H, 5.00; N, 11.25. 
7 
 
(Z)-3-Allyl-4-phenyl-2-(E)-1-phenylethylidene)hydrazono)-2,3-dihydrothiazole (6c). Pale yellow crystals 
(CH3CN), Rf = 0.7 (Toluene: Ethyl acetate: 10:1), yield 0.310 g (93%), m.p. 247-249 
oC (m.p. [28b] 246-
248 °C). Anal. calcd. for C20H19N3S (333.45): C, 72.04; H, 5.74; N, 12.60. Found: C, 72.16; H, 5.80; N, 
12.46. 
(Z)-3-Ethyl-4-phenyl-2-propan-2-ylidene)hydrazono)-2,3-dihydrothiazole (6d). Pale yellow crystals 
(CH3OH), Rf = 0.75 (Toluene: Ethyl acetate: 10:1), yield 0.202 g (78%), m.p. =97-98 
oC (lit [28b] 96 °C). 
Anal. calcd. for C14H17N3S (259.37): C, 64.83; H, 6.61; N, 16.20. Found: C, 64.70; H, 6.81; N, 16.36.   
(Z)-3-Ethyl-4-phenyl-2-(E)-1-phenylethylidene)hydrazono)-2,3-dihydrothiazole (6e). Pale yellow  
crystals (CH3OH), Rf = 0.8 (Toluene: Ethyl acetate: 10:1),  yield 0.302 g (94%), m.p. = 212-214 °C. 
1H 
NMR (400 MHz, CDCl3):  = 7.80-7.78 (m, 2H, Ph-H), 7.60-7.40 (m, 4H, Ph-H), 6.92 (s, 1H, thiazole-5), 
6.86-6.82 (m, 4H, Ph-H), 4.00 (q, 2H, J = 7.0 Hz, CH2-ethyl), 2.40 (s, 3H, CH3), 1.20 (t, 3H, J = 7.0 Hz, 
CH3-ethyl). 
13C NMR (400 MHz, CDCl3):  = 164.0, 155.0 (C=N), 139.0 (C-4-thiazole), 137.0 (Ph-2C), 
132.0, 131.0, 130.6, 130.0 (Ph-2CH), 127.0, 126.2 (Ph-CH), 102.0 (Thiazole-CH-5), 38.9 (CH2-ethyl), 21.0 
(CH3), 13.0 (CH3). Anal. calcd. for C19H19N3S (321.44): C, 71,00; H, 5.96; N, 13.07. Found: C, 71.10; H, 
6.00; N, 13.12. 
4. Conclusion 
In this paper, we illustrate a new method of synthesizing hydrazonothiazoles by one-pot reaction of 
substituted thiosemicarbazides, 2-bromoacetophenones and ketones. The advantages of our new method are; 
a) high yield percentages of the products, b) facile one pot method (at room temperature) and c) the 
illustrated method does not involve any additives. 
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